XT
ALLR

XTX Topco’s Allarity Therapeutics ALLR Stock Holding History

XTX Topco’s Portfolio ALLR Stock Details ALLR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.6K Sell
28,967
-4,677
-14% -$5.03K ﹤0.01% 3442
2025
Q4 		$36.3K Buy
+33,644
New +$42.9K ﹤0.01% 2911
2025
Q3 		– Sell
-50,950
Closed -$51.5K – 2516
2025
Q2 		$51.5K Buy
+50,950
New +$48.2K ﹤0.01% 2009

Other funds holding ALLR

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

XTX Topco's ALLR Position: Q1 2026 in Review

XTX Topco reduced its Allarity Therapeutics (ALLR) stake by 14% in Q1 2026, selling an estimated $5.03K and leaving 28,967 shares worth $31.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3442.

XTX Topco first reported a position in ALLR in Q2 2025 and has held it in 3 quarters since. The position peaked at $51.5K in Q2 2025. 14 funds tracked by Wall St. Rank hold ALLR as of Q1 2026.

  • XTX Topco held 28,967 shares of Allarity Therapeutics worth $31.6K as of Q1 2026.
  • XTX Topco sold 4,677 Allarity Therapeutics shares in Q1 2026, an estimated $5.03K.
  • Allarity Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3442 holding.
  • XTX Topco first reported a position in Allarity Therapeutics in Q2 2025 and has held it in 3 quarters since.
  • XTX Topco's Allarity Therapeutics position peaked at $51.5K in Q2 2025.
  • 14 funds tracked by Wall St. Rank held Allarity Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.